First-in-Class Products
Multiple MOA's
Product Strengths
Clinical Pipeline
Product Discovery
Partnerships
Executive Management Team
Advisors
Jennerex Story
Career Opportunities
Press Releases
Jennerex in the News
Events
Company
Patients
Gateways
News
FAQs
Contact Us
Site Map
Search
07/16/08
Jennerex Publishes Clinical Trial Data with Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated
Hepatitis B Virus
06/02/08
Jennerex Clinical Trial Data with JX-594 Selected for Plenary Session Presentation at Major International Conference
05/21/08
Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in
Lancet Oncology
11/08/07
Jennerex Appoints Bob Ingram Special Advisor and Hires Marty Glick as EVP, Corporate Strategy
10/23/07
Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
10/17/06
Jennerex and Green Cross Enter Agreement to Develop and Commercialize JX-594 In South Korea